Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online March 4, 2021.
Article Versions
- You are currently viewing an Earlier version of this article (March 4, 2021 - 09:47).
- View the most recent version of this article
Copyright & Usage
© 2020 The Authors. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited and is not used for commercial purposes.
Author Information
- Sekhar Surapaneni1,*,
- Usha Yerramilli2,
- April Bai2,
- Deepak Dalvie3,
- Jennifer Brooks4,
- Xiaomin Wang2,
- Julie V. Selkirk5,
- Yingzhuo Grace Yan5,
- Peijin Zhang6,
- Richard Hargreaves5,
- Gondi Kumar2,
- Maria Palmisano6, and
- Jonathan Q. Tran6
- 1Nonclinical Disposition and Bioanalysis, Bristol Myers Squibb, United States of America
- 2Nonclinical Research and Development, Bristol Myers Squibb, United States of America
- 3Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb, United States of America
- 4Drug Metabolism and Pharmacokinetics, Escient Pharmaceuticals, United States of America
- 5Neuroscience TRC, Bristol Myers Squibb, United States of America
- 6Clinical Pharmacology and Pharmacometrics, Bristol Myers Squibb, United States of America
- ↵* Corresponding Author:
Sekhar Surapaneni, Nonclinical Disposition and Bioanalysis, Bristol Myers Squibb, 556 Morris Avenue, Summit, New Jersey, 07901, United States of America. E-mail: sekhar.surapaneni{at}bms.com